Skip to main content

Akinsanya Karen

In the past year, 3 open-market sale filings worth $972.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$972.0K
3 filings
Net
−$972.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Akinsanya Karen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

SDGR Schrodinger, Inc.

See Remarks7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 21, 2026 (view filing)5:15 PM ETSep 174 daysAkinsanya KarenSee RemarksSSale−31.6K$29.37−$928.0K−31.1%70.0K after2 lots10b5-1
Mar 6, 2026 (view filing)Mar 51 dayAkinsanya KarenSee RemarksSSale−1.37K$12.90−$17.6K−1.9%70.0K after10b5-1
Mar 3, 2026 (view filing)Mar 21 dayAkinsanya KarenSee RemarksSSale−2.21K$11.99−$26.4K−3.0%71.3K after10b5-1
Apr 15, 2025 (view filing)Apr 141 dayAkinsanya KarenPresident of R&D, TherapeuticsSSale−16.7K$25.09−$419.5K−51.7%15.6K after3 lots10b5-1
Oct 19, 2021 (view filing)Oct 154 daysAkinsanya KarenSee RemarksSSale−1.39K$55.75−$77.7K−100.0%0 after
Sep 16, 2021 (view filing)Sep 151 dayAkinsanya KarenSee RemarksSSale−1.39K$61.13−$85.2K−100.0%0 after
Aug 17, 2021 (view filing)Aug 161 dayAkinsanya KarenSee RemarksSSale−37.7K$57.74−$2.18M−100.0%0 after2 lots